Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 4
1982 1
1996 2
2000 1
2003 2
2004 1
2008 1
2010 1
2011 3
2012 2
2016 1
2017 3
2018 5
2019 3
2020 3
2021 1
2022 4
2023 5
2024 5
2025 10
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
ADAPT NXT: Fixed Cycles or Every-Other-Week IV Efgartigimod in Generalized Myasthenia Gravis.
Habib AA, Claeys KG, Bril V, Hussain Y, Gwathmey K, Sahagian G, Cortés-Vicente E, Brauer E, Gelinas D, Sumbul A, Jimenez RH, Hristova D, Masschaele D, Mantegazza R, Meisel A, Attarian S; ADAPT NXT Study Group. Habib AA, et al. Ann Clin Transl Neurol. 2025 Jun;12(6):1162-1170. doi: 10.1002/acn3.70051. Epub 2025 Apr 14. Ann Clin Transl Neurol. 2025. PMID: 40223516 Free PMC article. Clinical Trial.
The ethics of hypopnea scoring.
Skolnik C, Attarian H. Skolnik C, et al. J Clin Sleep Med. 2024 Apr 1;20(4):615-617. doi: 10.5664/jcsm.10944. J Clin Sleep Med. 2024. PMID: 38063188 Free PMC article.
It is recommended that the American Academy of Sleep Medicine work with the Centers for Medicare & Medicaid Services to develop a scoring policy that consistently promotes individual sleep health regardless of payor. CITATION: Skolnik C, Attarian H. The ethics o …
It is recommended that the American Academy of Sleep Medicine work with the Centers for Medicare & Medicaid Services to develop a scorin …
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.
Al-Hakem H, Doets AY, Stino AM, Zivkovic SA, Andersen H, Willison HJ, Cornblath DR, Gorson KC, Islam Z, Mohammad QD, Sindrup SH, Kusunoki S, Davidson A, Casasnovas C, Bateman K, Miller JAL, van den Berg B, Verboon C, Roodbol J, Leonhard SE, Arends S, Luijten LWG, Benedetti L, Kuwabara S, Van den Bergh P, Monges S, Marfia GA, Shahrizaila N, Galassi G, Pereon Y, Bürmann J, Kuitwaard K, Kleyweg RP, Marchesoni C, Sedano Tous MJ, Querol L, Martín-Aguilar L, Wang Y, Nobile-Orazio E, Rinaldi S, Schenone A, Pardo J, Vermeij FH, Waheed W, Lehmann HC, Granit V, Stein B, Cavaletti G, Gutiérrez-Gutiérrez G, Barroso FA, Visser LH, Katzberg HD, Dardiotis E, Attarian S, van der Kooi AJ, Eftimov F, Wirtz PW, Samijn JPA, Gilhuis HJ, Hadden RDM, Holt JKL, Sheikh KA, Kolb N, Karafiath S, Vytopil M, Antonini G, Feasby TE, Faber C, Kramers H, Busby M, Roberts RC, Silvestri NJ, Fazio R, van Dijk GW, Garssen MPJ, Verschuuren J, Harbo T, Jacobs BC; IGOS Consortium. Al-Hakem H, et al. Neurology. 2023 Jun 6;100(23):e2386-e2397. doi: 10.1212/WNL.0000000000207282. Epub 2023 Apr 19. Neurology. 2023. PMID: 37076309 Free PMC article.
Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trial.
Kishnani PS, Díaz-Manera J, Illarioshkin S, van der Ploeg AT, Clemens PR, Day JW, Toscano A, Kushlaf H, Ladha S, Attarian S, Carvalho G, Kostera-Pruszczyk A, Erdem-Özdamar S, Goker-Alpan O, Mozaffar T, Straub V, Roberts M, Haack KA, Huynh-Ba O, Tammireddy S, Periquet M, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Kishnani PS, et al. J Neurol. 2025 Aug 16;272(9):581. doi: 10.1007/s00415-025-13266-y. J Neurol. 2025. PMID: 40817977 Free PMC article. Clinical Trial.
Sleep epilepsy.
Eisenman LN, Attarian HP. Eisenman LN, et al. Neurologist. 2003 Jul;9(4):200-6. doi: 10.1097/01.nrl.0000080951.78533.d1. Neurologist. 2003. PMID: 12864930 Review.
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.
Thomma RCM, Halstead SK, de Koning LC, Wiegers EJA, Gourlay DS, Tio-Gillen AP, van Rijs W, Andersen H, Antonini G, Arends S, Attarian S, Barroso FA, Bateman KJ, Benedetti L, Van den Bergh P, Bürmann J, Busby M, Casasnovas C, Dardiotis E, Davidson A, Feasby TE, Fehmi J, Galassi G, Garcia-Sobrino T, Granit V, Gutiérrez-Gutiérrez G, Hadden RDM, Harbo T, Hartung HP, Hasan I, Holt JKL, Islam Z, Karafiath S, Katzberg HD, Kolb N, Kusunoki S, Kuwabara S, Kuwahara M, Lehmann HC, Leonhard SE, Martín-Aguilar L, Monges S, Nobile-Orazio E, Pardo J, Pereon Y, Querol L, Reisin RC, Rinaldi S, Ripellino P, Roberts RC, Scheidegger O, Shahrizaila N, Sheikh KA, Silvestri NJ, Sindrup SH, Stein B, Tan CY, Tankisi H, Visser LH, Waheed W, Huizinga R, Jacobs BC, Willison HJ; IGOS consortium. Thomma RCM, et al. Brain. 2025 Nov 4;148(11):4000-4015. doi: 10.1093/brain/awaf102. Brain. 2025. PMID: 40096525 Free PMC article.
Autonomic dysfunction in idiopathic hypersomnia: an overlooked association and potential management.
Adra N, Reddy M, Attarian H, Sahni AS. Adra N, et al. J Clin Sleep Med. 2022 Mar 1;18(3):963-965. doi: 10.5664/jcsm.9818. J Clin Sleep Med. 2022. PMID: 34847990 Free PMC article. Review.
This article additionally presents the personal experience of one of the authors at the sleep center. CITATION: Adra N, Reddy M, Attarian H, Sahni AS. Autonomic dysfunction in idiopathic hypersomnia: an overlooked association and potential management. ...
This article additionally presents the personal experience of one of the authors at the sleep center. CITATION: Adra N, Reddy M, Attarian …
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial.
Koch JC, Leha A, Bidner H, Cordts I, Dorst J, Günther R, Zeller D, Braun N, Metelmann M, Corcia P, De La Cruz E, Weydt P, Meyer T, Großkreutz J, Soriani MH, Attarian S, Weishaupt JH, Weyen U, Kuttler J, Zurek G, Rogers ML, Feneberg E, Deschauer M, Neuwirth C, Wuu J, Ludolph AC, Schmidt J, Remane Y, Camu W, Friede T, Benatar M, Weber M, Lingor P; ROCK-ALS Study group. Koch JC, et al. Lancet Neurol. 2024 Nov;23(11):1133-1146. doi: 10.1016/S1474-4422(24)00373-9. Lancet Neurol. 2024. PMID: 39424560 Free PMC article. Clinical Trial.
54 results